XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 02, 2021
Sep. 26, 2020
Oct. 02, 2021
Sep. 26, 2020
Operating activities        
Net earnings (loss) $ (3,034) $ 89 $ (2,280) $ 4,457
Earnings from discontinued operations 0 3,964 0 17,429
Loss from continuing operations (3,034) (3,875) (2,280) (12,972)
Items not affecting cash:        
Depreciation and amortization 8,837 7,513 25,790 22,893
Amortization of debt issuance costs 359 1,019 993 3,023
Deferred income taxes 3,315 2,311 (179) 5,510
Stock-based compensation 1,250 3,435 9,593 7,425
Impairment of long-lived assets 0 0 2,962 0
Other (168) 238 (504) 211
Changes in operating assets and liabilities (5,494) (1,976) (77,472) 6,734
Net cash provided by (used in) operating activities of continuing operations 5,065 8,665 (41,097) 32,824
Net cash provided by operating activities of discontinued operations 0 11,496 0 24,751
Net cash provided by (used in) operating activities 5,065 20,161 (41,097) 57,575
Investing activities        
Additions to property, plant and equipment (18,386) (11,300) (34,989) (26,227)
Additions to intangible assets 0 0 (25,073) 0
Proceeds from sale of assets 950 0 2,300 0
Other 0 0 0 41
Net cash used in investing activities of continuing operations (17,436) (11,300) (57,762) (26,186)
Net cash used in investing activities of discontinued operations (0) (475) (13,380) (1,607)
Net cash used in investing activities (17,436) (11,775) (71,142) (27,793)
Financing activities        
Increase (decrease) under revolving credit facilities 11,348 3,410 123,177 (26,472)
Borrowings of long-term debt 4,739 0 9,380 0
Repayment of long-term debt (1,849) (624) (11,789) (1,702)
Payment of debt issuance costs (181) (3) (2,552) (2,491)
Proceeds from the exercise of stock options and employee share purchases 304 864 7,494 1,435
Payment of withholding taxes on stock-based awards (1,576) (1,225) (8,313) (2,376)
Payment of cash dividends on preferred stock (609) 0 (4,638) (1,700)
Payment of share issuance costs 0 0 (287) 0
Proceeds from issuance of preferred stock, net of issuance costs 0 0 0 26,804
Other 0 0 0 (4)
Net cash provided by (used in) financing activities of continuing operations 12,176 2,422 112,472 (6,506)
Net cash used in financing activities of discontinued operations (0) (11,510) (200) (23,847)
Net cash provided by (used in) financing activities 12,176 (9,088) 112,272 (30,353)
Increase (decrease) in cash and cash equivalents in the period (195) (702) 33 (571)
Cash and cash equivalents of discontinued operations:        
Balance at beginning of period 0 1,152 0 1,370
Foreign exchange gain on cash and cash equivalents 0 15 0 11
Less: balance at end of period 0 (678) 0 (678)
Cash and cash equivalent, beginning of the period 479 473 251 128
Cash and cash equivalents, end of the period $ 284 $ 260 $ 284 $ 260